Clinical Trials Logo

Filter by:
NCT ID: NCT03289624 Withdrawn - Family Caregivers Clinical Trials

SHARE for Persons With Chronic Conditions and Their Family Caregivers

SHARE-CC
Start date: August 15, 2017
Phase: N/A
Study type: Interventional

SHARE-CC is an intervention for families facing the challenges of chronic conditions. SHARE-CC (Support, Help, Activities, Resources, and Education) addresses the need for both members of a care dyad to be actively involved in current and future care planning. This intervention aims to increase knowledge of services, improve communication skills and well-being, and facilitate the understanding of care values and preferences in order to create a mutually agreed upon care plan. This intervention will be tested in a randomized control trial.

NCT ID: NCT03288935 Withdrawn - Emotional Stress Clinical Trials

Trauma Informed Care for Newly Resettled Refugees

Start date: August 28, 2018
Phase: N/A
Study type: Interventional

The main purpose of this study is to evaluate early-phase interventions for refugee wellness promotion and build evidence for dissemination of the intervention model and curricula through refugee resettlement programs, local and national.

NCT ID: NCT03288818 Withdrawn - Mycosis Fungoides Clinical Trials

Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides

Start date: August 2018
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well low dose total skin electron beam radiation therapy and mechlorethamine hydrochloride gel work in treating patients with mycosis fungoides. Total skin electron beam radiation therapy uses high energy x-rays directed at the entire surface of the body to kill cancer cells and shrink tumors. Mechlorethamine hydrochloride gel may help patients in remission of disease, reduction in disease staging, and enhanced quality of life. Giving total skin electron beam radiation therapy and mechlorethamine hydrochloride gel may work better in treating patients with mycosis fungoides.

NCT ID: NCT03286205 Withdrawn - Clinical trials for Anemia, Iron Deficiency

A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

Start date: April 14, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.

NCT ID: NCT03286166 Withdrawn - Dry Eye Clinical Trials

Single Center, Prospective, Randomized, Controlled, Non-significant Risk

Start date: December 1, 2021
Phase:
Study type: Observational

A randomized controlled trial to evaluate the efficiency of serum tears made with Genius PRP for improving signs and symptoms in Dry Eye Disease (DED). Single center, Prospective, Randomized, Controlled, Non-significant risk

NCT ID: NCT03284281 Withdrawn - Inflammation Clinical Trials

Low-Level Transcutaneous Vagus Stimulation in ST Segment Elevation Myocardial Infarction: TREAT MI Study

TREATMI
Start date: March 19, 2018
Phase: N/A
Study type: Interventional

This study will determine the impact of Transcutaneous Vagus Stimulation(TVNS) and autonomic modulation of inflammation in patients admitted with " acute heart attack." After admission for "acute heart attack" or "myocardial infarction" patients will be randomized to either TVNS or placebo and their blood samples will be collected at different time points during admission and post discharge. Blood samples will be analyzed for various markers of inflammation.

NCT ID: NCT03284047 Withdrawn - Gingival Exposure Clinical Trials

Botox for Gummy Smile

Start date: April 24, 2019
Phase: N/A
Study type: Interventional

This is a two part study to measure and observe the efficacy of botulinum toxin A for the treatment of gummy smiles. Part A will randomly compare three different doses of botulinum toxin type A (abobotulinumtoxin A) for the treatment of upper anterior gummy smile with larger gingival exposure (> 4 mm). Part B will assign one of two doses of botulinum toxin type A for participants with smaller gingival exposure (< 4 mm). Follow-up visits with photography will occur 4 and 12 weeks after their treatment. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. This study is a pilot study designed to determine feasibility of this procedure.

NCT ID: NCT03284021 Withdrawn - Alopecia Clinical Trials

Fraxel Laser for Alopecia

Start date: April 24, 2019
Phase: N/A
Study type: Interventional

This is a pilot study to evaluate the effect of the 1550 nm fractional erbium-glass laser in patients with nonscarring alopecias. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. Participants will receive 5 sessions of laser, 30 days apart, to the area of alopecia on the scalp. Follow-up is at 150 days. This study was a pilot study designed to determine feasibility of this procedure.

NCT ID: NCT03283865 Withdrawn - Clinical trials for Regional Anesthesia Morbidity

Does Use of Ultrasound Reduce the Rate of Sham Caudal Block in Children

Start date: June 30, 2017
Phase: N/A
Study type: Interventional

Caudal blocks are one of the most commonly performed regional anesthetics in children and are performed daily for a host of infra-umbilical surgical procedures. A caudal block is an epidural injection, most commonly of local anesthetic into the epidural space as accessed via the sacral hiatus. In children, the sacral hiatus is a normally occurring aperture in which the epidural space may be accessed with extremely minimal risk; as neural tissue ends more proximally. Due to this measure of safety, caudal blocks are preferred in children when compared with standard lumbar epidurals. Caudal blocks are performed blindly using palpation and tactile feedback to assess if the medication is being administered in the correct location. As a result of blind injection, administration of local anesthetic totally or partially outside of the correct site can often be unnoticed or identified after a significant volume has already been injected. With the potential for toxicity of local anesthetic, this may result in either the inability to give a complete dose or an unintentional and often unnoticed sham block "incorrect site of injection".

NCT ID: NCT03281681 Withdrawn - Ovarian Cancer Clinical Trials

A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer

REPROVe
Start date: March 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open label, multi-center, Phase 1/2 clinical trial in subjects with recurrent adenocarcinoma of the ovary who have been previously treated with a minimum of two courses of platinum-based chemotherapy, and up to two additional cytotoxic regimens that may also have included platinum (no more than four total lines of prior therapy), with or without bevacizumab, whose cancer has recurred within six months of the most recent platinum-based chemotherapy. All eligible subjects will receive VAL 083 i.v. in a once weekly cycle until disease progression, development of other unacceptable toxicity, death, withdrawal of consent, loss to follow-up, or Sponsor ending the study, whichever occurs first.